NTRA241220C50000
- 0.00
- 0.000.00%
Natera Newsroom
Insider Sale: EXECUTIVE CHAIRMAN of $NTRA (NTRA) Sells 5,300 Shares
Natera(NTRA.US) Officer Sells US$26.52 Million in Common Stock
Express News | Form 144 | Natera(NTRA.US) Director Proposes to Sell 26.63 Million in Common Stocks
Natera Is Maintained at Overweight by JP Morgan
Natera Analyst Ratings
J.P. Morgan Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $200
Natera Announces Enrollment Of First Patients In SAGITTARIUS A Randomized Phase III Clinical Trial In Colon Cancer; ~700-900 Patients Expected To Be Enrolled Across More Than 20 Sites
Express News | Natera Inc - 700-900 Patients Expected to Be Enrolled in Trial
Express News | Natera Announces Enrollment of First Patients in Sagittarius: A Randomized, Phase III Clinical Trial in Colon Cancer
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
Express News | Natera Inc : Leerink Partners Raises Target Price to $200 From $185
Natera and MyOme Announce Launch of IPRS for Breast Cancer Risk Assessment
Natera Aligns Executive Chairman's Pay With Performance
Natera(NTRA.US) Director Sells US$14.79 Million in Common Stock
Natera Insider Sold Shares Worth $14,793,563, According to a Recent SEC Filing
Insider Sale: Director at $NTRA (NTRA) Sells 40,171 Shares
Strong Volume Growth Lifted Natera (NTRA) in Q3
Express News | Form 144 | Natera(NTRA.US) Director Proposes to Sell 14.79 Million in Common Stocks
Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?
Looking Into Natera's Recent Short Interest